Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07YLO
|
|||
Former ID |
DNCL001735
|
|||
Drug Name |
SDF-1
|
|||
Synonyms |
JVS-100
Click to Show/Hide
|
|||
Indication | Heart failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9; ICD-9: 428] | Phase 2 | [1] | |
Peripheral arterial disease [ICD-11: BD4Z; ICD-10: I73, I73.9] | Phase 2 | [2] | ||
Company |
Juventas Therapeutics
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Stromal cell-derived factor 1 (CXCL12) | Target Info | Inhibitor | [3] |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Chemokine signaling pathway | ||||
NF-kappa B signaling pathway | ||||
Axon guidance | ||||
Leukocyte transendothelial migration | ||||
Intestinal immune network for IgA production | ||||
Pathways in cancer | ||||
Rheumatoid arthritis | ||||
NetPath Pathway | IL-7 Signaling Pathway | |||
TWEAK Signaling Pathway | ||||
Panther Pathway | Axon guidance mediated by Slit/Robo | |||
Pathway Interaction Database | CXCR4-mediated signaling events | |||
Syndecan-4-mediated signaling events | ||||
HIF-1-alpha transcription factor network | ||||
Reactome | Nuclear signaling by ERBB4 | |||
Chemokine receptors bind chemokines | ||||
G alpha (i) signalling events | ||||
WikiPathways | EV release from cardiac cells and their functional effects | |||
Signaling by ERBB4 | ||||
Allograft Rejection | ||||
miR-targeted genes in muscle cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01643590) Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.. U.S. National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 3 | SDF-1 in myocardial repair. Gene Ther. 2012 Jun;19(6):583-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.